The National Comprehensive Cancer Network
(NCCN) and the American Cancer Society (ACS) teamed up to provide patients
and the general public the most current information about treatment options
for breast cancer patients. The ACS has translated the NCCN breast cancer
treatment guidelines, originally developed for oncologists? use, into an
understandable language and format for patients. The new guidelines became
available on March 1, 1999.
"The NCCN Oncology Practice Guidelines, which now cover more than 95
percent of all cancer patients, have become the treatment standard for
oncology professionals," said William T. McGivney, PhD, Chief Executive
Officer of NCCN, a nationwide network of 17 cancer centers. "We are proud
our collaboration with the ACS will bring these guidelines to the patients
who need them most."
How the Guidelines Work
After studying research results on breast cancer treatment, a panel
of NCCN experts has agreed upon specific, up-to-date, recommendations for
treating women with this disease. These recommendations were formulated
using scientific evidence and currently accepted approaches to treatment.
Every year the panel will consider updating their recommendations, if advances
in medical science warrant it.
The guidelines are helping people better understand breast cancer and
their doctor?s advice. The treatment options for different stages of cancer
are presented as flow charts. For each stage, the chart shows step-by-step
how the patient and doctor can arrive at choices about treatment.
Categories used in the flow charts are: cancer stage (stages indicate
how far breast cancer has spread within the breast, to nearby tissues,
and to other organs); work-up (the tests done to help determine the initial
breast cancer diagnosis); treatment; prevention (what can be done to prevent
a recurrence of the disease); and follow-up.
For example, the stage for ductal carcinoma in situ (DCIS) is stage
0. The work-up is mammography of both breasts and biopsy and pathological
review of the biopsy sample. The treatment options vary depending on the
findings of the pathological review, but could include either a mastectomy
with or without reconstruction or a lumpectomy with or without radiation.
Prevention of a second cancer is an option, with a regimen of the drug
tamoxifen for five years. Follow-up includes medical history and physical
exam twice a year for five years, then once a year, along with a yearly
mammogram.
"Patients want detailed information about their treatment, so they can
work with their doctor to formulate a treatment plan that best fits their
needs, both medically and personally," said Ted Gansler, MD, MBA, director
of health content for the ACS.
"For more than 85 years, the public has relied on the American Cancer
Society for accurate, up-to-date information about cancer and its treatment,"
said Charles J. McDonald, MD, president of the ACS. "This joint effort
with the NCCN ensures that breast cancer patients will have the information
they need to better understand the disease and act, in conjunction with
their physician, to get treatment that is right for them."
ACS News Center stories are provided as a source of cancer-related
news and are not intended to be used as
press releases.
|